
|Videos|December 20, 2017
Results for Denosumab in Patients With Giant Cell Tumor of Bone
Author(s)Emanuela Palmerini, MD
Emanuela Palmerini, MD, Prometeo Laboratory: Clinical and Experimental Research Contract, Chemotherapy for Rare Musculoskeletal Tumors Department, Instituto Ortopedico Rizzoli, discusses efficacy results for denosumab (Xgeva) in patients with giant cell tumor of bone (GCTB).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Ziftomenib in NPM1-Mutant Acute Myeloid Leukemia
2
FDA Approves Novel Interchangeable Biosimilar for Pertuzumab in HER2+ Breast Cancer
3
Five-Year CAR T Data Reflect Long-Term PFS in Multiple Myeloma
4
FDA Grants Fast Track to Alnodesertib Combo for Metastatic Colorectal Cancer
5









































